HCRTR1 and Anxiety: Indeed, selective OX1R antagonists have been shown to reduce fear-related behavior (Soya and Sakurai 2020b; Steiner et al. 2013a) which suggests that daridorexant, via OX1R antagonism, could contribute to the reduction of anxiety and stress per se, in addition to the reduction of wakefulness.